eonatal complications of coronavirus disease (COVID-19) study

Not Applicable

Completed

• Conditions: COVID-19 (SARS-CoV-2 infection); Infections and Infestations

• Registration Number: ISRCTN60033461
• Lead Sponsor: niversity of Oxford

Brief Summary

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33181124/ Characteristics and outcomes of neonatal SARS-CoV-2 infection (added 16/02/2021) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36899124/ Neonatal outcomes of maternal SARS-CoV-2 infection (added 13/03/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37968087/ (added 16/11/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-07-31
• Study Completion: 2022-09-30
• Last Update Posted: 28 November 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

Two groups of babies are eligible for inclusion:
1. Babies who have a diagnosis of SARS-CoV-2 infection made on a sample taken in the first 28 days and received inpatient care on a postnatal ward, neonatal unit, paediatric inpatient ward or paediatric intensive care unit
2. Babies born to mothers with COVID-19 where the baby requires hospital care within the first 28 days after birth

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Observational
• Study Design: Not specified